Healthcare

Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.

IFC lending $147.5M to Jubilant Pharma

Healthcare

26 May, 2014

IFC lending $147.5M to Jubilant Pharma

International Finance Corporation (IFC), a member of the World Bank Group, is lending $147.5 million (Rs 865 crore) to Jubilant ......

Healthcare

26 May, 2014

Andhra HC lifts stay on Sun Pharma-Ranbaxy merger

The Andhra Pradesh High Court has vacated its stay order on the proposed merger of Ranbaxy Laboratories Ltd with Sun ......

Premium

Healthcare

23 May, 2014

Quadria-backed hospital chain Medica Synergie aims to triple its capacity in a year

Kolkata-headquartered hospital chain Medica Synergie Pvt Ltd, which is building up its presence in eastern region of the country, aims ......

Healthcare

23 May, 2014

SeQuent acquiring assets and business of Arvee Synthesis

Bangalore-based SeQuent Scientific Limited has entered into a definite agreement to acquire the manufacturing assets and business of Arvee Synthesis ......

Premium

Healthcare

23 May, 2014

VC-backed Mitra Biotech spruces up flagship diagnostic product

Bangalore-based Mitra Biotech Pvt Ltd, which focuses on personalised cancer care and rational drug development, has rebranded and is now ......

Premium

Healthcare

22 May, 2014

What's driving dental chain business in India

Single speciality segment has been one of the hottest areas within the broader healthcare sector. Indeed, one clear driver for ......

Healthcare

21 May, 2014

US FDA finds Sun Pharma's response to import ban inadequate

US drug regulator has said that Sun Pharma’s response to the ban on imports of products made at one of ......

Premium

Healthcare

21 May, 2014

Biomark Capital-backed Strand Life Sciences may float IPO by 2016

Bangalore-based Strand Life Sciences Pvt Ltd, which focuses on clinical genomics and research in biotechnology, aims to go for public ......

Healthcare

21 May, 2014

Mires puts total fair valuation of Dr Datsons at $60M

European pharma player Mires B.V has completed its valuation exercise as part of its interest to acquire majority stake in ......

Healthcare

19 May, 2014

AstraZeneca rejects Pfizer's final offer worth $118B

British drug maker AstraZeneca has rejected the fourth and final takeover offer worth $118 billion by Pfizer Inc on Monday ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News